Trials / Completed
CompletedNCT00476671
Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1
Prevalence and Risk Factors of HIV-associated Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1 Infected Thai Individuals With Undetectable Viral Load in the HAART Era.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- The HIV Netherlands Australia Thailand Research Collaboration · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess the prevalence and risk factors of neurocognitive impairment and psychiatric comorbidities in HIV infected patients who have undetectable viral load, have been on HAART for at least 1 year and have no history of CNS infection.
Detailed description
To understand how to prevent and treat HIV-associated neurocognitive impairment and psychiatric comorbidities in HIV-infected Thai individuals who don't have current AIDS related illness or current and prior central nervous system (CNS) infection, and have been well treated with HAART with undetectable HIV RNA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | lumbar puncture, MRI, MRS | lumbar puncture, MRI, MRS are only performed in patients with HIV associated dementia |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2008-04-01
- Completion
- 2008-06-01
- First posted
- 2007-05-22
- Last updated
- 2020-07-17
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT00476671. Inclusion in this directory is not an endorsement.